Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA
Links shared publicly online about this topic.
- 241total visits
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA
The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.
View full resource at oncologynurseadvisor.com
Tags: Cancer, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Eloxatin, Eloxatine, Science, Medical
Most Recently Shared on June 5, 2011 at 5:23 pm By:
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW
Advertisement
